312 related articles for article (PubMed ID: 21828966)
21. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.
Betts JW; Phee LM; Hornsey M; Woodford N; Wareham DW
Antimicrob Agents Chemother; 2014 Jun; 58(6):3541-6. PubMed ID: 24687491
[TBL] [Abstract][Full Text] [Related]
25. [Clinical characteristics of carbapenem-resistant
Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
[No Abstract] [Full Text] [Related]
26. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H
Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335
[TBL] [Abstract][Full Text] [Related]
27. Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.
Satlin MJ; Chen L; Patel G; Gomez-Simmonds A; Weston G; Kim AC; Seo SK; Rosenthal ME; Sperber SJ; Jenkins SG; Hamula CL; Uhlemann AC; Levi MH; Fries BC; Tang YW; Juretschko S; Rojtman AD; Hong T; Mathema B; Jacobs MR; Walsh TJ; Bonomo RA; Kreiswirth BN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167547
[TBL] [Abstract][Full Text] [Related]
28. Molecular epidemiology of KPC-2-producing Enterobacteriaceae (non-Klebsiella pneumoniae) isolated from Brazil.
Tavares CP; Pereira PS; Marques Ede A; Faria C; de Souza Mda P; de Almeida R; Alves Cde F; Asensi MD; Carvalho-Assef AP
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):326-30. PubMed ID: 25935630
[TBL] [Abstract][Full Text] [Related]
29. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
[TBL] [Abstract][Full Text] [Related]
30. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
[TBL] [Abstract][Full Text] [Related]
31. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
32. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis.
Bogan C; Kaye KS; Chopra T; Hayakawa K; Pogue JM; Lephart PR; Bheemreddy S; Lazarovitch T; Zaidenstein R; Perez F; Bonomo RA; Marchaim D
Am J Infect Control; 2014 Jun; 42(6):612-20. PubMed ID: 24837111
[TBL] [Abstract][Full Text] [Related]
34. A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.
de Maio Carrilho CM; de Oliveira LM; Gaudereto J; Perozin JS; Urbano MR; Camargo CH; Grion CM; Levin AS; Costa SF
BMC Infect Dis; 2016 Nov; 16(1):629. PubMed ID: 27809803
[TBL] [Abstract][Full Text] [Related]
35. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital.
Zhao ZC; Xu XH; Liu MB; Wu J; Lin J; Li B
Am J Infect Control; 2014 May; 42(5):e61-4. PubMed ID: 24773806
[TBL] [Abstract][Full Text] [Related]
36. Performance evaluation of three automated identification systems in detecting carbapenem-resistant Enterobacteriaceae.
He Q; Chen W; Huang L; Lin Q; Zhang J; Liu R; Li B
Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):40. PubMed ID: 27328762
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
[TBL] [Abstract][Full Text] [Related]
38. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
[TBL] [Abstract][Full Text] [Related]
39. Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae.
Little ML; Qin X; Zerr DM; Weissman SJ
Int J Antimicrob Agents; 2012 Jan; 39(1):52-7. PubMed ID: 22055532
[TBL] [Abstract][Full Text] [Related]
40. Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease.
Tian F; Li Y; Wang Y; Yu B; Song J; Ning Q; Jian C; Ni M
Ann Clin Microbiol Antimicrob; 2023 Jan; 22(1):10. PubMed ID: 36710337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]